Clinical Report: Comparative Analysis of Drug-Eluting Beads and Standard Bronchial Arterial Chemoembolization for Lung Cancer

Overview

This systematic review and meta-analysis compares the efficacy and safety of drug-eluting beads bronchial arterial chemoembolization (DEB-BACE) with conventional bronchial arterial chemoembolization (cBACE) in lung cancer patients.

Background

Lung cancer remains a leading cause of cancer-related mortality globally, particularly in China. Conventional bronchial arterial chemoembolization (cBACE) has been used as a palliative treatment for unresectable lung cancer.

Data Highlights

Key Findings

• DEB-BACE showed a higher pooled ORR at 1–3 months and 6 months compared to cBACE.
• DEB-BACE was associated with a higher pooled DCR at both 1–3 months and 6 months.
• No significant differences in adverse events such as hemoptysis, fever, or nausea/vomiting were observed between DEB-BACE and cBACE.
• The evidence is based on five studies from China involving 221 patients.

Clinical Implications

The findings suggest that DEB-BACE may provide superior short-term tumor response in lung cancer patients compared to cBACE, without a corresponding increase in adverse events. Clinicians should consider these results when evaluating treatment options for patients with unresectable lung cancer.

Conclusion

DEB-BACE appears to offer enhanced efficacy over cBACE in the short term for lung cancer treatment, though further research is needed to validate these findings.

Related Resources & Content

1. Frontiers in Oncology, 2026 -- Comparison between drug-eluting bead transarterial chemoembolization versus conventional TACE in elderly patients with colorectal cancer liver metastases: a cohort study
2. Frontiers in Immunology, 2026 -- Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety
3. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025 - PubMed
4. Safety and Effectiveness of Drug-Eluting Embolic Bronchial Arterial Chemoembolization for Lung Cancer: A Systematic Review and Meta-Analysis - PubMed
5. Frontiers in Cardiovascular Medicine — Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights
6. European Radiology — Safety and Efficacy of Small Particle Bronchial Artery Embolization: Insights from a 12-Year Single-Center Study
7. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025 - PubMed
8. Safety and Effectiveness of Drug-Eluting Embolic Bronchial Arterial Chemoembolization for Lung Cancer: A Systematic Review and Meta-Analysis - PubMed
9. CIRSE Standards of Practice on Bronchial Artery Embolisation - PMC